Kure Advisory’s Accenture ACN Stock Holding History

Kure Advisory’s Portfolio ACN Stock Details ACN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-798	Closed	-$280K	–	40
2023 Q4	$280K	Sell	798 -10	-1%	-$3.22K	0.15%	82
2023 Q3	$248K	Buy	+808	New	+$255K	0.14%	84

Other funds holding ACN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Kure Advisory's ACN Position: Q1 2024 in Review

Kure Advisory sold out of Accenture (ACN) in Q1 2024, closing a stake of 798 shares — an estimated $280K sold.

Kure Advisory first reported a position in ACN in Q3 2023 and held it in 2 quarters. The position peaked at $280K in Q4 2023. 2,342 funds tracked by Wall St. Rank hold ACN as of Q1 2024.

Kure Advisory reported no remaining Accenture position as of Q1 2024 after selling out during the quarter.
Kure Advisory sold 798 Accenture shares in Q1 2024, an estimated $280K.
Kure Advisory first reported a position in Accenture in Q3 2023 and held it in 2 quarters.
Kure Advisory's Accenture position peaked at $280K in Q4 2023.
2,342 funds tracked by Wall St. Rank held Accenture as of Q1 2024.

Based on Kure Advisory's 13F filing for Q1 2024, filed 9 May 2024.